By Associate Professor Venessa Therese Chin

Journal articles

Laidsaar-Powell R; Butow P; Brown BB; Mander K; Young J; Stone E; Chin V; Banks E; Lim CYS; Rankin NM, 2024, 'Application of a revised model for coping with advanced cancer to qualitatively explore lung cancer survivors’ experiences of ongoing physical effects, novel treatments, uncertainty, and coping', Journal of Cancer Survivorship, 18, pp. 1754 - 1770, http://dx.doi.org/10.1007/s11764-023-01417-x

Brown B; Young J; Galpin K; Boyer M; Chin V; Brown C; Simes RJ, 2024, 'Impact of COVID-19 on lung cancer care in New South Wales, Australia: real-world data from the EnRICH Program', Public Health Research and Practice, 34, http://dx.doi.org/10.17061/phrp3432423

Itchins M; Liang S; Brown C; Barnes T; Marx G; Chin V; Kao S; Yip PY; Mersiades AJ; Nagrial A; Bray V; Peters G; Parakh S; Garg K; Li BT; McKay M; O'Byrne K; John T; Gill AJ; Molloy MP; Solomon BJ; Pavlakis N, 2024, 'ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance', JTO Clinical and Research Reports, 5, http://dx.doi.org/10.1016/j.jtocrr.2024.100703

Pham JP; Zdanska O; Selga M; Javier J; O'Grady A; Chin V; Forstner D; Hsu E; Liu J, 2024, 'Onkolytische Viren zur Verstärkung der PD-1-Hemmung bei metastasierendem kutanem Plattenepithelkarzinom', JDDG - Journal of the German Society of Dermatology, 22, pp. 1016 - 1019, http://dx.doi.org/10.1111/ddg.15423_g

Lim JWY; Chin VT; Keith P; McCloy R; Neavin D; Xue A; Kaczorowski D; Spenceley E; Arora H; Joshua AM; Powell J, 2024, 'Predicting immunotherapy toxicity through single-cell sequencing of peripheral immune cells: A pilot study.', Journal of Clinical Oncology, 42, pp. e14538 - e14538, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e14538

McNamee N; Harvey C; Gray L; Khoo T; Lingam L; Zhang B; Nindra U; Yip PY; Pal A; Clay T; Arulananda S; Itchins M; Pavlakis N; Kao S; Bowyer S; Chin V; Warburton L; Pires da Silva I; John T; Solomon B; Alexander M; Nagrial A, 2024, 'Brief Report: Real-World Toxicity and Survival of Combination Immunotherapy in Pleural Mesothelioma—RIOMeso', Journal of Thoracic Oncology, 19, pp. 636 - 642, http://dx.doi.org/10.1016/j.jtho.2023.11.014

Brown B; Galpin K; Simes J; Boyer M; Brown C; Chin V; Young J, 2024, 'Development of clinically meaningful quality indicators for contemporary lung cancer care, and piloting and evaluation in a retrospective cohort; experiences of the Embedding Research (and Evidence) in Cancer Healthcare (EnRICH) Program', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-074399

Laidsaar-Powell R; Butow P; Brown B; Mander K; Young J; Stone E; Chin V; Banks E; Lim CYS; Rankin NM, 2024, 'Carrying on with life as a lung cancer survivor: a qualitative study of Australian survivors’ employment, finances, relationships, and healthcare experiences', Translational Lung Cancer Research, 13, pp. 785 - 798, http://dx.doi.org/10.21037/tlcr-23-815

Pham JP; Zdanska O; Selga M; Javier J; O'Grady A; Chin V; Forstner D; Hsu E; Liu J, 2024, 'Oncolytic viruses to augment PD-1 inhibition in metastatic cutaneous squamous cell carcinoma', JDDG - Journal of the German Society of Dermatology, 22, pp. 1016 - 1018, http://dx.doi.org/10.1111/ddg.15423

Colevas AD; Kerrigan K; Chin V; Rainey N; Park JJ; Fang B; Costa DA; Dinis J; Phan M; Lin L; Zhang Y; Sun SCC; Howland M; Curtis K; Adkins D, 2024, 'Safety and Tolerability of Magrolimab Combination Therapy in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (RM-HNSCC)', International Journal of Radiation Oncology*Biology*Physics, 118, pp. e85 - e86, http://dx.doi.org/10.1016/j.ijrobp.2024.01.190

Lim J; Chin V; Fairfax K; Moutinho C; Suan D; Ji H; Powell JE, 2023, 'Transitioning single-cell genomics into the clinic', Nature Reviews Genetics, 24, pp. 573 - 584, http://dx.doi.org/10.1038/s41576-023-00613-w

Colevas ADD; Dinis J; Chin VT; Costa DA; Park JJ; Fang B; Phan MD; Zhang Y; U'Ren L; Odegard J; Curtis KK; Pirtle E; Adkins D, 2023, 'A phase 2 study of magrolimab combination therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma: ELEVATE HNSCC.', Journal of Clinical Oncology, 41, pp. TPS6102 - TPS6102, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.tps6102

Nindra U; Hurwitz J; Forstner D; Chin V; Gallagher R; Liu J, 2023, 'A systematic review of neoadjuvant and definitive immunotherapy in locally advanced head and neck squamous cell carcinoma', Cancer Medicine, 12, pp. 11234 - 11247, http://dx.doi.org/10.1002/cam4.5815

Stephens EKH; Marshall HM; Chin V; Fong KM, 2023, 'Air pollution and lung cancer—A new era', Respirology, 28, pp. 313 - 315, http://dx.doi.org/10.1111/resp.14464

Smith AE; Kane A; Watts F; Qiu M; Chin V, 2023, 'Two Very Rare Cases of Metastatic Thymic Carcinoma with Sjogren's Syndrome: A Case Series', Case Reports in Oncology, 16, pp. 122 - 129, http://dx.doi.org/10.1159/000529425

Chan WY; Sim HW; Abdi Haryono M; Yip D; Chin V, 2023, 'Immune checkpoint inhibitors for advanced pancreatic cancer', Cochrane Database of Systematic Reviews, 2023, http://dx.doi.org/10.1002/14651858.CD014523

Brown BB; Galpin K; Simes RJ; Boyer M; Chin V; Young J; On Behalf Of The Clinical Advisory Group , 2023, 'Clinicians' Evaluation of Lung Cancer Clinical Quality Indicators and Comparative Performance Data in Practice', European Journal of Cancer Care, 2023, http://dx.doi.org/10.1155/2023/6636704

McNamee N; Harvey C; Gray L; Khoo T; Lingam L; Zhang B; Clay T; Arulananda S; Itchins M; Pavlakis N; Kao S; Bowyer S; Chin V; Warburton L; da Silva I; John T; Solomon B; Alexander M; Nagrial A, 2023, 'MA17.05 Real World Outcomes of Immunotherapy (IO) for Pleural MESOthelioma in Australia - RIOMeso', Journal of Thoracic Oncology, 18, pp. S163 - S163, http://dx.doi.org/10.1016/j.jtho.2023.09.239

Itchins M; Liang S; Brown C; Barnes T; Marx G; Chin V; Kao S; Yip PY; Mersiades AJ; Nagrial A; Bray V; Peters G; Parakh S; John T; Li M; Li BT; McKay M; Molloy M; O'Byrne K; Lee C; Gill A; Solomon BJ; Pavlakis N, 2023, 'P2.10-01 ALKTERNATE: A Pilot Study Alternating Lorlatinib with Crizotinib in Patients with ALK+ NSCLC and ALK-inhibitor Resistance', Journal of Thoracic Oncology, 18, pp. S351 - S352, http://dx.doi.org/10.1016/j.jtho.2023.09.616

Aziz D; Lee C; Chin V; Fernandez KJ; Phan Z; Waring P; Caldon CE, 2022, 'High cyclin E1 protein, but not gene amplification, is prognostic for basal-like breast cancer', Journal of Pathology: Clinical Research, 8, pp. 355 - 370, http://dx.doi.org/10.1002/cjp2.269

Wai Siu DH; O'Neill RS; Harris CA; Wang J; Ardolino L; Downton T; Tong M; Hong JH; Chin V; Clingan PR; Aghmesheh M; Soudy H, 2022, 'Immune checkpoint inhibitor-induced myocarditis, myositis, myasthenia gravis and transaminitis: a case series and review', Immunotherapy, 14, pp. 511 - 520, http://dx.doi.org/10.2217/imt-2021-0225

Lim J; Murphy A; Wong S; Nagrial A; Karikios D; Daneshvar D; McCloy R; Steinmann AM; O'Toole S; Chin V, 2022, 'Activin-A, Growth Differentiation Factor-11 and Transforming Growth Factor-β as predictive biomarkers for platinum chemotherapy in advanced non-small cell lung cancer', Cancer Treatment and Research Communications, 32, http://dx.doi.org/10.1016/j.ctarc.2022.100576

Laidsaar-Powell R; Butow P; Brown B; Mander K; Young J; Stone E; Chin V; Banks E; Lim C; Rankin N, 2022, 'EP10.01-005 Australian Lung Cancer Survivors Experiences of Novel Treatments, Healthcare, and Ongoing Physical and Psychological Needs', Journal of Thoracic Oncology, 17, pp. S502 - S502, http://dx.doi.org/10.1016/j.jtho.2022.07.882

Chin V; Arora H; Senabouth A; Hernandez JA; McCloy R; Simes J; Boyer M; Hogg P; Young J; Joshua A; Brown B; Watkins N; Powell J, 2022, 'EP16.03-041 Single Cell RNA Sequencing Reveals Phenotypic Predispositions to Developing Lung Cancer in Never-Smokers', Journal of Thoracic Oncology, 17, pp. S608 - S608, http://dx.doi.org/10.1016/j.jtho.2022.07.1102

Nieto P; Elosua-Bayes M; Trincado JL; Marchese D; Massoni-Badosa R; Salvany M; Henriques A; Nieto J; Aguilar-Fernández S; Mereu E; Moutinho C; Ruiz S; Lorden P; Chin VT; Kaczorowski D; Chan CL; Gallagher R; Chou A; Planas-Rigol E; Rubio-Perez C; Gut I; Piulats JM; Seoane J; Powell JE; Batlle E; Heyn H, 2021, 'A single-cell tumor immune atlas for precision oncology', Genome Research, 31, pp. 1913 - 1926, http://dx.doi.org/10.1101/gr.273300.120

Nagrial A; Chantrill L; Chin V; Sjoquist K; O'Connor CA; Yip D, 2021, 'Pharmacologic and radiotherapeutic interventions for advanced pancreatic cancer', Cochrane Database of Systematic Reviews, 2021, http://dx.doi.org/10.1002/14651858.CD010584.pub2

Floros P; Rao A; McCloy RA; Sim HW; Chin VT; Leavers BC; Crawford JA; Gallagher RM, 2021, 'Altered presentation of oropharyngeal cancer, a 6-year review', ANZ Journal of Surgery, 91, pp. 1240 - 1245, http://dx.doi.org/10.1111/ans.16537

Rajal AG; Marzec KA; McCloy RA; Nobis M; Chin V; Hastings JF; Lai K; Kennerson M; Hughes WE; Vaghjiani V; Timpson P; Cain JE; Watkins DN; Croucher DR; Burgess A, 2021, 'A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinoma', eLife, 10, http://dx.doi.org/10.7554/eLife.65234

Dreyer SB; Upstill-Goddard R; Paulus-Hock V; Paris C; Lampraki EM; Dray E; Serrels B; Caligiuri G; Rebus S; Plenker D; Galluzzo Z; Brunton H; Cunningham R; Tesson M; Nourse C; Bailey UM; Jones MD; Moran-Jones K; Wright DW; Duthie F; Oien K; Evers L; McKay CJ; McGregor GA; Gulati A; Brough R; Bajrami I; Pettitt S; Dziubinski ML; Candido J; Balkwill F; Barry ST; Grützmann R; Rahib L; Allison S; Bailey PJ; Biankin AV; Beraldi D; Cameron E; Chang DK; Cooke SL; Grimwood P; Kelly S; Marshall J; Martin S; McDade B; McElroy D; Musgrove EA; Ramsay D; Wright D; Hair J; Jamieson NB; Westwood P; Williams N; Johns AL; Mawson A; Scarlett CJ; Brancato MAL; Rowe SJ; Simpson SH; Martyn-Smith M; Thomas MT; Chantrill LA; Chin VT; Chou A; Cowley MJ; Humphris JL; Mead RS; Nagrial AM; Pajic M; Pettit J; Pinese M; Rooman I; Wu J; Tao J; DiPietro R; Watson C; Steinmann A; Lee HC; Wong R; Pinho AV; Giry-Laterriere M; Daly RJ; Sutherland RL; Grimmond SM; Waddell N; Kassahn KS; Miller DK; Wilson PJ; Patch AM; Song S; Harliwong I; Idrisoglu S; Nourbakhsh E; Manning S; Wani S; Gongora M; Anderson M; Holmes O; Leonard C; Biankin A; Toon CCW; Pavey D; Merrett N; asghari R; Chang D; Pereira B, 2021, 'Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer', Gastroenterology, 160, pp. 362 - 377.e13, http://dx.doi.org/10.1053/j.gastro.2020.09.043

Itchins M; Liang S; Barnes T; Marx G; Chin V; Kao S; Yip PY; Nagrial A; Peters G; Bray V; Lewis C; Shaffer T; Li M; Clarke S; Li B; Brown C; Solomon B; Pavlakis N, 2021, 'P24.03 Dynamic Circulating Tumor DNA Interim Results From The ALKternate Clinical Trial', Journal of Thoracic Oncology, 16, pp. S1030 - S1032, http://dx.doi.org/10.1016/j.jtho.2021.08.368

Lim J; Wong S; Murphy A; Nagrial A; Karikios D; Daneshvar D; Mccloy R; Murphy A; O'Toole S; Chin V; Watkins N, 2021, 'P37.19 Activin-A and GDF-11 as Predictive Biomarkers for Platinum Response in Non-Small Cell Lung Cancer', Journal of Thoracic Oncology, 16, pp. S450 - S450, http://dx.doi.org/10.1016/j.jtho.2021.01.766

Chin V; Stone E; Havryk A; Plit M; Mccloy R; Murphy A; Field A; Watkins N; Powell J, 2021, 'P60.01 Single-Cell Transcriptomics to Assess Response to Immunotherapy in Advanced Lung Cancer ex-vivo: Developing a Functional Predictive Assay', Journal of Thoracic Oncology, 16, pp. S540 - S541, http://dx.doi.org/10.1016/j.jtho.2021.01.960

Dreyer SB; Pinese M; Jamieson NB; Scarlett CJ; Colvin EK; Pajic M; Johns AL; Humphris JL; Wu J; Cowley MJ; Chou A; Nagrial AM; Chantrill L; Chin VT; Jones MD; Moran-Jones K; Carter CR; Dickson EJ; Samra JS; Merrett ND; Gill AJ; Kench JG; Duthie F; Miller DK; Cooke S; Aust D; Knösel T; Rümmele P; Grützmann R; Pilarsky C; Nguyen NQ; Musgrove EA; Bailey PJ; McKay CJ; Biankin AV; Chang DK, 2020, 'Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer', Annals of Surgery, 272, pp. 366 - 376, http://dx.doi.org/10.1097/SLA.0000000000003143

Hastings JF; Rajal AG; Latham SL; Han JZR; McCloy RA; O’donnell YEI; Phimmachanh M; Murphy AD; Nagrial A; Daneshvar D; Chin V; Watkins DN; Burgess A; Croucher DR, 2020, 'Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinoma', eLife, 9, pp. 1 - 25, http://dx.doi.org/10.7554/eLife.53367

Lim JWY; Murphy AD; O'Toole S; Nagrial A; Karikios DJ; Daneshvar D; Murphy A; McCloy R; Watkins N; Chin VT, 2020, 'Activin as a biomarker for platinum resistance in non-small cell lung cancer.', Journal of Clinical Oncology, 38, pp. e21737 - e21737, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e21737

Brunton H; Caligiuri G; Cunningham R; Upstill-Goddard R; Bailey UM; Garner IM; Nourse C; Dreyer S; Jones M; Moran-Jones K; Wright DW; Paulus-Hock V; Nixon C; Thomson G; Jamieson NB; McGregor GA; Evers L; McKay CJ; Gulati A; Brough R; Bajrami I; Pettitt SJ; Dziubinski ML; Barry ST; Grützmann R; Brown R; Curry E; Allison S; Biankin AV; Chang DK; Cooke SL; Grimwood P; Kelly S; Marshall J; McDade B; McElroy D; Ramsay D; Rebus S; Hair J; Westwood P; Williams N; Duthie F; Johns AL; Mawson A; Scarlett CJ; Brancato MAL; Rowe SJ; Simpson SH; Martyn-Smith M; Thomas MT; Chantrill LA; Chin VT; Chou A; Cowley MJ; Humphris JL; Mead RS; Nagrial AM; Pajic M; Pettit J; Pinese M; Rooman I; Wu J; Tao J; DiPietro R; Watson C; Steinmann A; Lee HC; Wong R; Pinho AV; Giry-Laterriere M; Daly RJ; Musgrove EA; Sutherland RL; Grimmond SM; Waddell N; Kassahn KS; Miller DK; Wilson PJ; Patch AM; Song S; Harliwong I; Idrisoglu S; Nourbakhsh E; Manning S; Wani S; Gongora M; Anderson M; Holmes O; Leonard C; Taylor D; Wood S; Xu C; Nones K; Fink JL; Christ A; Bruxner T; Cloonan N; Newell F; Pearson JV; Quinn M, 2020, 'HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer', Cell Reports, 31, http://dx.doi.org/10.1016/j.celrep.2020.107625

Wilson BE; Routy B; Nagrial A; Chin VT, 2020, 'The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies', Cancer Immunology, Immunotherapy, 69, pp. 343 - 354, http://dx.doi.org/10.1007/s00262-019-02453-2

Duffy AM; Halaki M; Spigelman A; Chin V; Gallagher RM; Flood VM, 2020, 'Nutritional parameters associated with hospital admissions in patients being treated for head and neck cancer', Supportive Care in Cancer, 28, pp. 341 - 349, http://dx.doi.org/10.1007/s00520-019-04826-w

Gonzalez-Rajal A; Marzec K; McCloy R; Nobis M; Chin V; Hastings J; Lai K; Kennerson M; Hughes W; Vaghjiani V; Timpson P; Cain J; Neil Watkins D; Croucher D; Burgess A, 2020, 'A Non-Genetic, Cell Cycle Dependent Mechanism of Platinum Resistance in Lung Adenocarcinoma', , http://dx.doi.org/10.1101/2020.11.26.400499

Leong TL; Gayevskiy V; Steinfort DP; De Massy MR; Gonzalez-Rajal A; Marini KD; Stone E; Chin V; Havryk A; Plit M; Irving LB; Jennings BR; McCloy RA; Jayasekara WSN; Alamgeer M; Boolell V; Field A; Russell PA; Kumar B; Gough DJ; Szczepny A; Ganju V; Rossello FJ; Cain JE; Papenfuss AT; Asselin-Labat ML; Cowley MJ; Watkins DN, 2019, 'Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer', Oncogene, 38, pp. 1661 - 1675, http://dx.doi.org/10.1038/s41388-018-0536-1

Patel S; Chin V; Greenfield JR, 2019, 'Durvalumab-induced diabetic ketoacidosis followed by hypothyroidism', Endocrinology, Diabetes and Metabolism Case Reports, 2019, http://dx.doi.org/10.1530/EDM-19-0098

Aziz D; Lee C; Chin V; Fernandez K; Etemadmoghadam D; Bowtell D; Waring PM; Caldon CE, 2019, 'Cyclin E1 is a shared biomarker of subsets of high grade serous ovarian cancer (HGSOC) and basal like breast cancer (BLBC)', Annals of Oncology, 30, pp. ix86 - ix86, http://dx.doi.org/10.1093/annonc/mdz426.029

Chou A; Froio D; Nagrial AM; Parkin A; Murphy KJ; Chin VT; Wohl D; Steinmann A; Stark R; Drury A; Walters SN; Vennin C; Burgess A; Pinese M; Chantrill LA; Cowley MJ; Molloy TJ; Waddell N; Johns A; Grimmond SM; Chang DK; Biankin AV; Sansom OJ; Morton JP; Grey ST; Cox TR; Turchini J; Samra J; Clarke SJ; Timpson P; Gill AJ; Pajic M, 2018, 'Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer', Gut, 67, pp. 2142 - 2155, http://dx.doi.org/10.1136/gutjnl-2017-315144

Lam S; Myers R; Atkar-Khattra S; Yuan R; Yee J; English J; Grant K; Lee A; Mcguire A; McWilliams A; Brims F; Stone E; Chin V; Chantrill L; Connellan M; Plitt M; Marshall H; Yang I; Bowman R; Fong K; Mayo J, 2018, 'Prospective Evaluation of the Clinical Utility of the International Lung Screen Trial Lung Nodule Management Protocol', JOURNAL OF THORACIC ONCOLOGY, 13, pp. S362 - S363, http://dx.doi.org/10.1016/j.jtho.2018.08.332

Rogers S; McCloy RA; Parker BL; Gallego-Ortega D; Law AMK; Chin VT; Conway JRW; Fey D; Millar EKA; O’Toole S; Deng N; Swarbrick A; Chastain PD; Cesare AJ; Timpson P; Caldon CE; Croucher DR; James DE; Watkins DN; Burgess A, 2018, 'MASTL overexpression promotes chromosome instability and metastasis in breast cancer', Oncogene, 37, pp. 4518 - 4533, http://dx.doi.org/10.1038/s41388-018-0295-z

Marini KD; Croucher DR; McCloy RA; Vaghjiani V; Gonzalez-Rajal A; Hastings JF; Chin V; Szczepny A; Kostyrko K; Marquez C; Samantha W; Jayasekara N; Alamgeer M; Boolell V; Han JZR; Waugh T; Lee HC; Oakes SR; Kumar B; Harrison CA; Hedger MP; Lorensuhewa N; Kita B; Barrow R; Robinson BW; De Kretser DM; Wu J; Ganju V; Alejandro Sweet-Cordero E; Burgess A; Martelotto LG; Rossello FJ; Cain JE; Neil Watkins D, 2018, 'Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy', Science Translational Medicine, 10, http://dx.doi.org/10.1126/scitranslmed.aat3504

Pokorny AMJ; Chin VT; Nagrial AM; Yip D; Chantrill LA, 2018, 'Metastatic pancreatic ductal adenocarcinoma: diagnosis and treatment with a view to the future', Internal Medicine Journal, 48, pp. 637 - 644, http://dx.doi.org/10.1111/imj.13810

Balachandran VP; Łuksza M; Zhao JN; Makarov V; Moral JA; Remark R; Herbst B; Askan G; Bhanot U; Senbabaoglu Y; Wells DK; Cary CIO; Grbovic-Huezo O; Attiyeh M; Medina B; Zhang J; Loo J; Saglimbeni J; Abu-Akeel M; Zappasodi R; Riaz N; Smoragiewicz M; Larkin Kelley Z; Basturk O; Gönen M; Levine AJ; Allen PJ; Fearon DT; Merad M; Gnjatic S; Iacobuzio-Donahue CA; Wolchok JD; Dematteo RP; Chan TA; Greenbaum BD; Merghoub T; Leach SD; Johns AL; Scott Mead R; Gill AJ; Chang DK; McKay SH; Chantrill LA; Chin VT; Chou A; Humphris JL; Pajic M; Steinmann A; Arshi M; Drury A; Froio D; Morgan A; Timpson P; Hermann D; Vennin C; Warren S; Pinese M; Wu J; Pinho AV; Tucker K; Andrews L; Samra JS; Arena J; Pavlakis N; High HA; Mittal A; Biankin AV; Bailey P; Martin S; Musgrove EA; Jones MD; Nourse C; Jamieson NB; Stoita A; Williams D; Spigelman A; Waddell N; Pearson JV; Patch AM; Nones K; Newell F; Mukhopadhyay P; Addala V; Kazakoff S; Holmes O; Leonard C; Wood S; Xu C; Grimmond SM; Hofmann O; Wilson PJ; Christ A; Bruxner T; Asghari R; Merrett ND; Pavey D; Das A; Goodwin A; Cosman PH; Ismail K, 2017, 'Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer', Nature, 551, pp. S12 - S16, http://dx.doi.org/10.1038/nature24462

Scarpa A; Hang DKC; Nones K; Corbo V; Patch A-M; Bailey P; Lawlor RT; Johns AL; Miller DK; Mafficini A; Rusev B; Scardoni M; Antonello D; Barbi S; Sikora KO; Cingarlini S; Vicentini C; McKay S; Quinn MCJ; Bruxner TJC; Christ AN; Harliwong I; Idrisoglu S; McLean S; Nourse C; Nourbakhsh E; Wilson PJ; Anderson MJ; Fink JL; Newell F; Waddell N; Holmes O; Kazakoff SH; Leonard C; Wood S; Xu Q; Nagaraj SH; Amato E; Dalai I; Bersani S; Cataldo I; Tos APD; Capelli P; Davi MV; Landoni L; Malpaga A; Miotto M; Whitehall VLJ; Leggett BA; Harris JL; Harris J; Jones MD; Humphris J; Hantrill LAC; Chin V; Nagrial AM; Pajic M; Scarlett CJ; Pinho A; Rooman I; Toon C; Wu J; Pinese M; Cowley M; Barbour A; Mawson A; Humphrey ES; Colvin EK; Chou A; Lovell JA; Jamieson NB; Duthie F; Gingras M-C; Fisher WE; Dagg RA; Lau LMS; Lee M; Pickett HA; Reddel RR; Samra JS; Kench JG; Merrett ND; Epari K; Nguyen NQ; Zeps N; Falconi M; Simbolo M; Butturini G; Van Buren G; Partelli S; Fassan M; Khanna KK; Gill AJ; Wheeler DA; Gibbs RA; Musgrove EA; Bassi C; Tortora G; Pederzoli P; Pearson JV; Waddell N; Biankin AV; Grimmond SM, 2017, 'Whole-genome landscape of pancreatic neuroendocrine tumours (vol 543, pg 65, 2017)', NATURE, 550, pp. 548 - 548, http://dx.doi.org/10.1038/nature24026

Chin VT; Vennin C; Timpson P; Pajic M, 2017, 'Effective modulation of stromal signaling through ROCK inhibition: Is it all in the timing?', Molecular and Cellular Oncology, 4, http://dx.doi.org/10.1080/23723556.2017.1333973

Back to profile page